Literature DB >> 7592570

The ferrochelatase gene structure and molecular defects associated with erythropoietic protoporphyria.

S Taketani1, H Fujita.   

Abstract

Ferrochelatase [heme synthase, protoheme ferrolyase (EC 4.99.1.1)], the terminal enzyme of the heme biosynthetic pathway, catalyzes the incorporation of ferrous ion into protoporphyrin IX to form protoheme IX. The genes and cDNAs for ferrochelatase from mammals and micro-organisms have been isolated. The gene for human ferrochelatase has been mapped to chromosome 18q 21.3 and consists of 11 exons with a size of about 45 kilodaltons. The induction of ferrochelatase expression occurs during erythroid differentiation, and can be attributed to the existence of the promoter sequences of erythroid-related genes. Analysis of the ferrochelatase gene in patients with erythropoietic protoporphyria, an inherited disease caused by ferrochelatase defects, revealed that molecular anomalies of ferrochelatase from 11 patients were found in 9 patients as autosomal dominant type, and 2 patients as recessive type. Diversity of the mutations of the ferrochelatase gene is also briefly described.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7592570     DOI: 10.1007/BF02110038

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  52 in total

1.  Study of factors causing excess protoporphyrin accumulation in cultured skin fibroblasts from patients with protoporphyria.

Authors:  J R Bloomer; D A Brenner; M J Mahoney
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

2.  Characterization of ferrochelatase in kidney and erythroleukemia cells.

Authors:  Y Nakahashi; S Taketani; Y Sameshima; R Tokunaga
Journal:  Biochim Biophys Acta       Date:  1990-03-01

Review 3.  [Molecular biology of sideroblastic anemia and porphyria].

Authors:  H Fujita; T Nagai
Journal:  Seikagaku       Date:  1993-01

4.  A novel mutation in erythropoietic protoporphyria: an aberrant ferrochelatase mRNA caused by exon skipping during RNA splicing.

Authors:  X Wang; M Poh-Fitzpatrick; D Carriero; L Ostasiewicz; T Chen; S Taketani; S Piomelli
Journal:  Biochim Biophys Acta       Date:  1993-04-30

5.  Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease.

Authors:  S Tutois; X Montagutelli; V Da Silva; H Jouault; P Rouyer-Fessard; K Leroy-Viard; J L Guénet; Y Nordmann; Y Beuzard; J C Deybach
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

6.  Mammalian ferrochelatase. Expression and characterization of normal and two human protoporphyric ferrochelatases.

Authors:  H A Dailey; V M Sellers; T A Dailey
Journal:  J Biol Chem       Date:  1994-01-07       Impact factor: 5.157

7.  Nonsense mutations in the dihydrofolate reductase gene affect RNA processing.

Authors:  G Urlaub; P J Mitchell; C J Ciudad; L A Chasin
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

8.  Bovine protoporphyria: documentation of autosomal recessive inheritance and comparison with the human disease through measurement of heme synthase activity.

Authors:  J R Bloomer; K O Morton; R J Reuter; G R Ruth
Journal:  Am J Hum Genet       Date:  1982-03       Impact factor: 11.025

9.  Molecular defect in human erythropoietic protoporphyria with fatal liver failure.

Authors:  Y Nakahashi; H Miyazaki; Y Kadota; Y Naitoh; K Inoue; M Yamamoto; N Hayashi; S Taketani
Journal:  Hum Genet       Date:  1993-05       Impact factor: 4.132

10.  Molecular defects in erythropoietic protoporphyria with terminal liver failure.

Authors:  X Schneider-Yin; B W Schäfer; P Möhr; G Burg; E I Minder
Journal:  Hum Genet       Date:  1994-06       Impact factor: 4.132

View more
  2 in total

1.  The low expression allele (IVS3-48C) of the ferrochelatase gene leads to low enzyme activity associated with erythropoietic protoporphyria.

Authors:  Tsuyoshi Tahara; Masayoshi Yamamoto; Reiko Akagi; Hideo Harigae; Shigeru Taketani
Journal:  Int J Hematol       Date:  2010-12-04       Impact factor: 2.490

2.  Loss of ferrochelatase is protective against colon cancer cells: ferrochelatase a possible regulator of the long noncoding RNA H19.

Authors:  Rémi Safi; Tala Mohsen-Kanson; Georges Nemer; Batoul Dekmak; Nelly Rubeiz; Marwan El-Sabban; Dany Nassar; Assaad Eid; Ossama Abbas; Abdul-Ghani Kibbi; Mazen Kurban
Journal:  J Gastrointest Oncol       Date:  2019-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.